Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Early Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis: A Narrative Review
H Alsomali, Evelyn Palmer, Avinash Aujayeb, et al.
Pulmonary Therapy (2023) Vol. 9, Iss. 2, pp. 177-193
Open Access | Times Cited: 25

Showing 25 citing articles:

The bronchoalveolar lavage fluid CD44 as a marker for pulmonary fibrosis in diffuse parenchymal lung diseases
Magda Suchánková, Eszter Zsemlye, Ján Urban, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 2
Vistusertib improves pulmonary inflammation and fibrosis by modulating inflammatory/oxidative stress mediators via suppressing the mTOR signalling
Taslim B. Shaikh, Yogesh Chandra, Sai Balaji Andugulapati, et al.
Inflammation Research (2024) Vol. 73, Iss. 7, pp. 1223-1237
Closed Access | Times Cited: 4
Establishment of an Early Warning Screening System for High Risk Population in High Incidence Area of Esophageal Cancer, Gansu province, northwestern China: A Retrospective Population-Based Study
Duojie Zhu, Chengyun Li, Yinggang Che, et al.
Research Square (Research Square) (2025)
Closed Access
Insight into the efficacy and safety of pirfenidone: The treatment of idiopathic pulmonary fibrosis
Liying Xu, Y. Yu, Lu-Sha Cen
World Journal of Clinical Cases (2025) Vol. 13, Iss. 14
Closed Access
Advances in the Pathogenesis of Idiopathic Pulmonary Fibrosis
姝文 赵
Journal of Clinical Personalized Medicine (2025) Vol. 04, Iss. 01, pp. 39-45
Open Access
Iguratimod improves bleomycin-induced pulmonary inflammation and fibrosis by regulating macrophage polarization through inhibiting the TLR4/NF-κB pathway
Huan Xu, Koval' Ma, Z. Ma, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
CD206 and dust particles are prognostic biomarkers of progressive fibrosing interstitial lung disease associated with air pollutant exposure
Aliaksei Kadushkin, Olga Yudina, Nastassia Lukashevich, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
qPulmoFib Imaging: A novel quantitative evaluation method based on optical imaging technology for precise staging and early diagnosis of idiopathic pulmonary fibrosis in animal models
Lishuang Li, Jing Gong, Yuan Ma, et al.
Optics and Lasers in Engineering (2025) Vol. 190, pp. 108882-108882
Open Access
Treatment of Bleomycin-induced Pulmonary Fibrosis by Intratracheal Instillation Administration of Ellagic Acid-Loaded Chitosan Nanoparticles
Zhilin Luo, Yao Sun, Shihao Cai, et al.
AAPS PharmSciTech (2025) Vol. 26, Iss. 4
Closed Access
Identification and analysis of extracellular matrix and epithelial-mesenchymal transition-related genes in idiopathic pulmonary fibrosis by bioinformatics analysis and experimental validation
Xiangfei Huang, Wen Yu, Juan Tian, et al.
Gene (2025), pp. 149464-149464
Closed Access
Widening Patient Engagement for Rare Disease Drug Trials: The Perspectives of Patients With Idiopathic Pulmonary Fibrosis on Participating in Clinical Drug Trials and Drug Trial Design
Julia Frost, Jessica Mandizha, Steve Jones, et al.
Health Expectations (2025) Vol. 28, Iss. 2
Open Access
Identification of pyrazole scaffold inhibitors targeting cyclin-dependent kinase 8 for potential use in pulmonary fibrosis
Tony Eight Lin, Kai‐Cheng Hsu, Ching-Hsuan Chou, et al.
Biochemical Pharmacology (2025), pp. 116959-116959
Open Access
Context-Driven Active Contour (CDAC): A Novel Medical Image Segmentation Method Based on Active Contour and Contextual Understanding
Suane Pires P. da Silva, Roberto F. Ivo, Calleo Belo Barroso, et al.
Sensors (2025) Vol. 25, Iss. 9, pp. 2864-2864
Open Access
Validation of the recording of idiopathic pulmonary fibrosis in routinely collected electronic healthcare records in England
Ann Morgan, Rikisha Gupta, Peter M. George, et al.
BMC Pulmonary Medicine (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 9
ELIPF: Explicit Learning Framework for Pre-Emptive Forecasting, Early Detection and Curtailment of Idiopathic Pulmonary Fibrosis Disease
Tagne Poupi Theodore Armand, Md Ariful Islam Mozumder, Kouayep Sonia Carole, et al.
BioMedInformatics (2024) Vol. 4, Iss. 3, pp. 1807-1821
Open Access | Times Cited: 2
Presence of focal usual interstitial pneumonia is a key prognostic factor in progressive pulmonary fibrosis
Yukio Tsushima, Ethan N. Okoshi, Sousuke Ishijima, et al.
Histopathology (2024) Vol. 85, Iss. 1, pp. 104-115
Open Access | Times Cited: 1
A composite score based on cardiovascular parameters can predict the mortality risk of patients with newly diagnosed interstitial lung disease: A prospective observational study
Yu‐Wei Chen, Chih‐Hung Lai, Yu-Wan Liao, et al.
Journal of Cardiology (2024) Vol. 84, Iss. 4, pp. 287-293
Closed Access | Times Cited: 1
Lichen planus pigmentosus‐like reaction to pirfenidone in a patient with idiopathic pulmonary fibrosis
Marijana Vičić, Nika Hlača, Katarina Skender, et al.
International Journal of Dermatology (2024)
Closed Access | Times Cited: 1
Memahami Penyakit Paru Interstisial: Pengenalan Dini pada Layanan Kesehatan Primer
Altama Latona Sidarta, Menaldi Rasmin
Cermin Dunia Kedokteran (2024) Vol. 51, Iss. 4, pp. 200-206
Open Access
Current challenges in the diagnosis and management of idiopathic pulmonary fibrosis in Japan
Masashi Bando, Hirofumi Chiba, Yasunari Miyazaki, et al.
Respiratory Investigation (2024) Vol. 62, Iss. 5, pp. 785-793
Closed Access
Research priorities for progressive pulmonary fibrosis in the UK
Laura Fabbri, Anne‐Marie Russell, Nazia Chaudhuri, et al.
BMJ Open Respiratory Research (2024) Vol. 11, Iss. 1, pp. e002368-e002368
Open Access
Identifying new molecular signatures and potential therapeutics for idiopathic pulmonary fibrosis: a network medicine approach
Mecbure Nur Akca, Ceyda Kasavi
Mammalian Genome (2024)
Closed Access
Biomarkers for Early Diagnosis of Idiopathic Pulmonary Fibrosis: A Systematic Review
Keke Zhai, Dawei Zang, Shuguang Yang, et al.
Journal of Medical and Biological Engineering (2024) Vol. 44, Iss. 5, pp. 666-675
Open Access
Qpulmofib Imaging: A Novel Quantitative Evaluation Method Based on Optical Imaging Technology for Precise Staging and Early Diagnosis of Idiopathic Pulmonary Fibrosis in Animal Models
Lishuang Li, Jing Gong, Yuan Ma, et al.
(2024)
Closed Access
Platelet indices and idiopathic pulmonary fibrosis: a multivariable mendelian randomization study
Yu Zheng, Yixuan Liang, Lingyun Zhu, et al.
Research Square (Research Square) (2024)
Open Access
Page 1

Scroll to top